Overview

Pycnogenol® in Post-COVID-19 Condition

Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
To determine the effect of Pycnogenol® versus placebo on patient-reported health status in people with post COVID-19 condition.
Phase:
Phase 3
Details
Lead Sponsor:
University of Zurich
Treatments:
Pycnogenols